Riskpilot← Back to searchSign inGet full accessBiofeedback Norden AB
ABActiveOrg 5567343503Boställevägen 2Business and other management consultancy activities · NACE 7020Est. 20070 employees
Revenue 2025
SEK 6K
-98% vs 2024
EBITDA margin
-219.8%
+83% vs 2024
Equity ratio
-20.1%
Financial strength
Net profit 2025
SEK -47K
+59% vs 2024
| Revenue | SEK 6K | -98% |
| EBITDA | SEK -12K | +83% |
| Net profit | SEK -47K | +59% |
| Total assets | SEK 146K | -48% |
| Equity | SEK -29K | -270% |
| Employees | 0 | — |
Legal name
Biofeedback Norden AB
Org number
5567343503
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
5 juli 2007
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Aktiebolagets verksamhet ska vara att marknadsföra och tillhandahålla produkter, utbildning och tjänster inom HRV Träning (HRV Hjärt Rytm variation) och biofeedback. Verksamheten riktar sig till konsulter inom stresshantering i Norden samt globalt genom samarbetspartners.
Address
Boställevägen 2
Phone
+46738027435
Email
anders@heartmath.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 489 | 600 | 372 | 225 | 6 |
| Staff expenses | — | −66 | −66 | −66 | −0 |
| EBITDA | 101 | 141 | −24 | −70 | −12 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 101 | 141 | −24 | −70 | −12 |
| Net financials | −50 | −50 | −47 | −44 | −34 |
| Profit before tax | 52 | 92 | −71 | −114 | −47 |
| Tax | −0 | — | — | — | — |
| Net profit | 52 | 92 | −71 | −114 | −47 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 500 | 517 | 455 | 279 | 146 |
| Equity | 110 | 202 | 131 | 17 | −29 |
| Long-term debt | 241 | 298 | 302 | 209 | 171 |
| Short-term debt | 148 | 17 | 22 | 53 | 4 |
| Total debt | 389 | 315 | 324 | 262 | 175 |
EBITDA margin
-219.8%
This company
15.8%
Market median
-1491% vs market
20212025
Equity ratio
-20.1%
This company
38.2%
Market median
-153% vs market
20212025
Return on equity
-4659000.0%
This company
18.4%
Market median
-25320752% vs market
20212025
Net profit margin
-847.1%
This company
8.1%
Market median
-10558% vs market
20212025
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
5.98×
This company
0.62×
Market median
-865% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biofeedback Norden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Anders Nilsson | Chief Executive Officer | 0 companies |
| Jenny Nilsson | Deputy Board Member | 0 companies |